Global and United States Biologics Safety Testing Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Biologics Safety Testing Market
This report focuses on global and United States Biologics Safety Testing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Biologics Safety Testing market size is estimated to be worth US$ 2653.5 million in 2022 and is forecast to a readjusted size of US$ 3976.4 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, by Type, Endotoxin Tests accounting for % of the Biologics Safety Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharmaceutical was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
Global Biologics Safety Testing Scope and Market Size
Biologics Safety Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biologics Safety Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Biologics Safety Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others

Segment by Application
Pharmaceutical
Medical Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon